DeJarnette Announces the Release of dyseCT.

Business Editors

TOWSON, Md.--(BUSINESS WIRE)--Oct. 31, 2003

DeJarnette Research Systems, Inc., known for its PACS connectivity expertise, has today announced the initial product release of dyseCT(TM), the company's solution to the problem of information overload produced by today's high speed, multi-slice CT scanners. The company had demonstrated dyseCT (TM) as a work-in-progress at the most recent SCAR and PACS 2003 trade shows.

High-speed CT scanners produce multiple procedure studies within a single acquisition. A PACS matches these multiple procedure studies to a single order. This causes several workflow inefficiencies:

-- Hospitals use manual processes to bill for the unmatched

orders

-- The modality worklist presented to the CT scanner contains

multiple entries - one for each procedure - and is difficult

to clear out

-- When it's time to pre-fetch a multiple procedure study as a

prior examination, there is no information in the PACS

regarding the unmatched orders to help an intelligent

pre-fetching algorithm.

dyseCT(TM) is a unique, high value, low cost solution to this long-standing PACS problem:

-- it identifies multiple procedure studies and modifies the

DICOM modality worklist using a group procedure to replace the

multiple procedures

-- it analyzes the images, associating them with a specific

anatomical region automatically and without manual

intervention

-- it separates the images in a multiple procedure study and

associates those images with the appropriate orders

-- at the same time, dyseCT(TM) acts as a DICOM linear VOI LUT 

gateway for all CT procedures.

dyseCT(TM) has undergone clinical evaluation at the company's Akron General Medical Center partner site. "The clinical trials of this product went more smoothly than any other product in my memory, either at DeJarnette or other companies I have worked for", stated Wayne DeJarnette, Ph.D., President of DeJarnette Research Systems. Dr. DeJarnette continued, "that is not to say we did not learn from the clinical testing process, it just seems like the product worked clinically from day one." Marilyn Schultz, the Administrative Director of Radiology for Akron General Medical Center stated, "dyseCT(TM) has been a success at AGMC, some docs (radiologists) have approached me to say how well they thought it worked, and even expressed surprise that it is possible to accomplish what dyseCT(TM) does, without human intervention." Dr. Charles Stockham, the product manager for dyseCT(TM) and DeJarnette Executive Vice President noted, "there are still some small issues to work out with the algorithm, based on our clinical experience so far, but these are minor issues and will be addressed well before volume shipments commence."

Additional clinical evaluation is underway at PACS sites managed by some of DeJarnette's Channel Partners for the dyseCT(TM) product. DeJarnette intends to announce a number of new Channel Partners, for dyseCT(TM), just prior to the RSNA tradeshow. The dyseCT(TM) product roadmap calls for additional clinical trials, on numerous makes and models of CT scanners, through the end of the year. Official product release is anticipated November 1, 2003. Company developers and clinical evaluators are also scheduled to give papers, detailing the clinical issues, at the PACS 2004, University of Rochester conference and SCAR 2004.

About DeJarnette

DeJarnette Research Systems, Inc. is a world leader in medical imaging interface technology, dedicated to increasing the efficiency of image management workflow for all types of health care institutions. Founded in 1985, the Towson, Maryland-based company develops, manufactures, sells, and services PACS and Teleradiology systems, as well as imaging interfacing hardware and software solutions. DeJarnette maintains an ISO 9001 and TickIT certified quality management system, and has been honored twice consecutively by inclusion in the INC. 500's annual list of fast growing privately held companies.